Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity
New England Journal of Medicine · 05.11.2026 · 395 (18) · 1781-1793
DOI: 10.1056/nejmoa2604169 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 05.11.2026. Verfasst von Ania M Jastreboff und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Endocrinology and Metabolism), Yale University School of Medicine, New Haven, CT. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Glucagon-Like Peptide-1 Receptor Agonists, Obesity, Receptors, Gastrointestinal Hormone. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Eli Lilly and Company.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine (Endocrinology and Metabolism), Yale University School of Medicine, New Haven, CT.
- Department of Pediatrics (Pediatric Endocrinology), Yale University School of Medicine, New Haven, CT.
- Yale Obesity Research Center (Y-Weight), Yale University School of Medicine, New Haven, CT.
- Obesity and Metabolism Institute, Boston.
- Diabetes Research Centre, University of Leicester, Leicester, United Kingdom.
- NIHR Leicester Biomedical Research Centre, Leicester, United Kingdom.
ORCID-Profile: Ania M Jastreboff, Megan Murray
Förderung
- Eli Lilly and Company
Zitieren
APA
Jastreboff, A. M., Kaplan, L. M., Davies, M. J., Wilding, J. P. H., Ahmad, N. N., Murray, M., Du, Y., Makarova, N., Giblin, K., Schloot, N. C., Wang, Y., & TRIUMPH-1 Investigators (2026). Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity. New England Journal of Medicine, 395(18), 1781-1793. https://doi.org/10.1056/nejmoa2604169
Vancouver
Jastreboff AM, Kaplan LM, Davies MJ, Wilding JPH, Ahmad NN, Murray M, et al. Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity. New England Journal of Medicine. 2026;395(18):1781-1793. doi:10.1056/nejmoa2604169
BibTeX
@article{Jastreboff2026,
author = {Jastreboff, Ania M and Kaplan, Lee M and Davies, Melanie J and Wilding, John P H and Ahmad, Nadia N and Murray, Megan and Du, Yu and Makarova, Nune and Giblin, Kathryn and Schloot, Nanette C and Wang, Yan and TRIUMPH-1 Investigators, TRIUMPH-1 Investigators},
title = {Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {18},
pages = {1781--1793},
doi = {10.1056/nejmoa2604169}
}
EUVIMED